abstract |
The present invention relates to compositions and methods comprising a chimeric antigen receptor (CAR) capable of binding fibroblast activation protein (TAP) for use in treating diseases, disorders or conditions associated with the expression of TAP on canine, mouse, or human tumor-associated cells. |